secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0000882095-23-000019
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead stockholders approve director slate, ESPP amendments; three shareholder proposals defeated
--------------------------------------------------------------------------------

- All nine director nominees elected with majority support; highest vote for Bluestone (995.9M for), lowest for Lofton (925.9M for).
- Ernst & Young ratified as auditor for FY2023 with 1,047M for vs 63.8M against.
- Say-on-pay passed with 919.1M for (92.0% of votes cast); future votes set to annual.
- ESPP amendments approved (996.9M for) authorizing additional 25M shares, plan extended to 2033.
- Three stockholder proposals defeated: proxy access nominee (7.4M for), special meeting rights (46.4M for), patent exclusivity report (165.4M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000088209523000019/0000882095-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000088209523000019/gild-20230503.htm
  HTML page:      https://secwatch.observer/filing/0000882095-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer